- Home
- ESEA vs DCTH Comparison
ESEA vs DCTH Comparison
Compare ESEA & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- DCTH
- Stock Information
- Founded
- ESEA 2005
- DCTH 1988
- Country
- ESEA Greece
- DCTH United States
- Employees
- ESEA N/A
- DCTH N/A
- Industry
- ESEA Marine Transportation
- DCTH Medical/Dental Instruments
- Sector
- ESEA Consumer Discretionary
- DCTH Health Care
- Exchange
- ESEA Nasdaq
- DCTH Nasdaq
- Market Cap
- ESEA 208.2M
- DCTH 485.5M
- IPO Year
- ESEA 2006
- DCTH N/A
- Fundamental
- Price
- ESEA $47.51
- DCTH $12.50
- Analyst Decision
- ESEA Strong Buy
- DCTH Strong Buy
- Analyst Count
- ESEA 1
- DCTH 4
- Target Price
- ESEA $62.00
- DCTH $24.00
- AVG Volume (30 Days)
- ESEA 43.5K
- DCTH 785.8K
- Earning Date
- ESEA 06-18-2025
- DCTH 08-04-2025
- Dividend Yield
- ESEA 5.47%
- DCTH N/A
- EPS Growth
- ESEA 21.86
- DCTH N/A
- EPS
- ESEA 18.62
- DCTH N/A
- Revenue
- ESEA $222,525,034.00
- DCTH $53,850,000.00
- Revenue This Year
- ESEA $5.14
- DCTH $155.42
- Revenue Next Year
- ESEA $3.76
- DCTH $37.93
- P/E Ratio
- ESEA $2.55
- DCTH N/A
- Revenue Growth
- ESEA 14.62
- DCTH 1068.87
- 52 Week Low
- ESEA $24.58
- DCTH $7.17
- 52 Week High
- ESEA $50.82
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- ESEA 71.35
- DCTH 33.81
- Support Level
- ESEA $43.60
- DCTH $13.30
- Resistance Level
- ESEA $47.88
- DCTH $14.15
- Average True Range (ATR)
- ESEA 1.97
- DCTH 0.64
- MACD
- ESEA -0.13
- DCTH -0.26
- Stochastic Oscillator
- ESEA 60.30
- DCTH 8.28
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.